NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Buried in the details of a new 20-year distribution agreement between Valeant Pharmaceuticals International Inc. and Walgreens Boots Alliance Inc. is a $150 million financial hit to Valeant that underscores the unusual nature of the deal. The amount reflects the one-time revenue impact on Valeant of the drug-distribution pact, according…

news

Actelion Ltd, Europe's biggest biotech firm, has won approval from the U.S. Food and Drug Administration to bring a key follow-up to its original lung blockbuster to the American market. The Swiss company said selexipag, approved to delay disease progression and reduce risk of hospitalisation for pulmonary arterial hypertension (PAH),…

news

Pfizer Inc does not owe New York University any royalties on the lung cancer drug Xalkori, a New York state judge ruled in an opinion issued Friday. Manhattan Supreme Court Justice Shirley Werner Kornreich granted Pfizer's motion to dismiss the breach of contract lawsuit filed in 2013 by NYU, which…

news

French drugmaker Sanofi said on Wednesday it had submitted an application to the U.S. Food and Drug Administration (FDA) for a single daily insulin injection to treat adults with type 2 diabetes. Sanofi said it had requested a six-month review of its new drug application by the FDA, rather than…

news

Drugmaker KaloBios Pharmaceuticals Inc (KBIO.O) said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of…

news

Kangmei Pharmaceutical Co Ltd says in strategic agreement to invest at least 600 million yuan ($92.60 million) to set up hospital in Guangdong province.   reuters.com

news

Drug firm Strides Shasun has received approval from the Drug Controller General of India (DCGI) to produce a generic version of Gilead's 'Sovaldi' used for treatment of Hepatitis C. The company has received approval for manufacturing a generic version of Sofosbuvir 400 mg, Strides Shasun today said in a filing…

news

Shares in India's largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India's generic drug industry. The warning comes barely a month after rival Dr Reddy's Laboratories Ltd was reprimanded…

news

Bionpharma, a New Jersey-based pharmaceutical startup founded last year by five former Ranbaxy executives and backed by strategic and financial investors, has acquired a portfolio of approximately 25 products from specialty drug maker Banner Life Sciences. The combined revenue of the acquired products is estimated at more than $70 million…

news

The National Institutes of Health (NIH) released the NIH-Wide Strategic Plan, Fiscal Years 2016–2020: Turning Discovery Into Health, which will ensure the agency remains well positioned to capitalise on new opportunities for scientific exploration and address new challenges for human health. Developed after hearing from hundreds of stakeholders and scientific…